Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation
…, A Tauziede-Espariat, A Mackay, S Ghermaoui… - Acta …, 2020 - Springer
Diffuse midline gliomas (DMG) H3 K27M-mutant was introduced in the 2016 WHO Classification
of Tumors of the Central Nervous System, unifying diffuse intrinsic pontine gliomas (…
of Tumors of the Central Nervous System, unifying diffuse intrinsic pontine gliomas (…
[HTML][HTML] Diffuse midline glioma invasion and metastasis rely on cell-autonomous signaling
…, Y Ajlil, S Vairy, M Lancien, S Ghermaoui… - Neuro …, 2024 - ncbi.nlm.nih.gov
Background Diffuse midline gliomas (DMG) are pediatric tumors with negligible 2-year survival
after diagnosis characterized by their ability to infiltrate the central nervous system. In the …
after diagnosis characterized by their ability to infiltrate the central nervous system. In the …
Copy-number alterations reshape the classification of diffuse intrinsic pontine gliomas. First exome sequencing results of the BIOMEDE trial
…, C Chappe, N Entz-Werlé, A Moussa, S Ghermaoui… - medRxiv, 2021 - medrxiv.org
Diffuse intrinsic pontine gliomas (DIPG) is an incurable neoplasm occurring mainly in children
for which no progress was made in the last decades. The randomized phase II BIOMEDE …
for which no progress was made in the last decades. The randomized phase II BIOMEDE …
Diffuse midline glioma invasion and metastasis rely on cell-autonomous signaling through a phenotypic switch controlled by BMP7
…, L Midjek, Y Ajlil, S Vairy, M Lancien, S Ghermaoui… - Cancer Research, 2024 - AACR
Diffuse midline gliomas (DMG) are pediatric tumors with negligible two-year survival after
diagnosis characterized by their ability to infiltrate the central nervous system. In the hope of …
diagnosis characterized by their ability to infiltrate the central nervous system. In the hope of …
PDTM-36. WHOLE EXOME SEQUENCING (WES) OF DIPG PATIENTS FROM THE BIOMEDE TRIAL REVEALS NEW PROGNOSTIC SUBGROUPS WITH SPECIFIC …
…, AI Bertozzi, E De Carli, C Chappé, S Ghermaoui… - Neuro …, 2019 - ncbi.nlm.nih.gov
BACKGROUND & METHODS. The BIOlogical MEdicines for DIPG Eradication (BIOMEDE)
trial is a randomized multi-arm multi-stage program (drop-the-loser adaptive design). The first …
trial is a randomized multi-arm multi-stage program (drop-the-loser adaptive design). The first …
DIPG-38. PATIENT-DERIVED THREE-DIMENSIONAL AVATARS REVEAL CELL-AUTONOMOUS MECHANISMS DRIVING INVASION AND METASTATIC …
…, Y Ajlil, S Vairy, M Lancien, S Ghermaoui… - Neuro …, 2023 - ncbi.nlm.nih.gov
Diffuse midline gliomas H3K27-altered are pediatric tumors associated with dismal survival
after diagnosis that are characterized by their ability to infiltrate the entire central nervous …
after diagnosis that are characterized by their ability to infiltrate the entire central nervous …
DIPG-58. HISTONE H3 WILD-TYPE DIPG/DMG OVEREXPRESSING EZHIP EXTEND THE SPECTRUM OF DIFFUSE MIDLINE GLIOMAS WITH PRC2 INHIBITION …
…, A Tauziède-Espariat, A Mackay, S Ghermaoui… - Neuro …, 2020 - ncbi.nlm.nih.gov
Diffuse midline gliomas (DMG) H3 K27M-mutant were introduced in the 2016 WHO Classification
unifying diffuse intrinsic pontine gliomas (DIPG) and gliomas from the thalamus and …
unifying diffuse intrinsic pontine gliomas (DIPG) and gliomas from the thalamus and …
University Students Academic Usage of Facebook. Case Study: Licence 2 English Students, Mostaganem University
A Ghermaoui - Arab World English Journal (AWEJ) Volume, 2018 - papers.ssrn.com
… As a way of example, An Algerian researcher named Samia Ouaj undertook a survey at
the Unversity of Settif, Department of Foreign Languages which included 197 students and 35 …
the Unversity of Settif, Department of Foreign Languages which included 197 students and 35 …
[CITATION][C] Muslim Women Oppression through Ahdaf Soueif's” Melody and “1964”
N Ghermaoui - 2015 - University of Tlemcen